Frank Palella, MD, is working towards increasing the lifespan and “healthspan” of people living with HIV through research, education and patient care as director of the new Potocsnak Center for Aging and HIV.
A new drug has been shown to be highly effective against pediatrics infections caused by respiratory syncytial virus (RSV).
A new combination of antiviral drugs did not improve clinical outcomes in hospitalized patients with severe influenza, warranting further investigation into new therapeutic strategies, according to a recent clinical trial.
Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic’s impact on women and sexual and gender minorities.
A recent Northwestern Medicine study found global efforts to track variants grossly underreported a probable variant of concern, Eta, circulating in Nigeria in early 2021.
Respiratory syncytial virus infection during infancy results in metabolic reprogramming in epithelial cells lining the airway, according to a recent study.
Human cells use a protein named TBC1D5 to “trap and kill” influenza A viruses inside host cells, but the virus encodes its own protein to disable this defense.
Northwestern Medicine is part of the research team on a $185 million NIH project that will explore the millions of genetic variants that cause disease around the world.
Northwestern Medicine scientists continue to investigate all aspects of the COVID-19 pandemic: from molecular mechanisms of infection, to child hospitalization and single-dose vaccine response.
The Institute for Global Health (IGH) has established the Center for Pathogen Genomics and Microbial Evolution which will apply lessons learned during the COVID-19 pandemic to the tracking and prevention of future threats.